NEXT Oncology

Futó vizsgálatok

• Még nem toboroz

  A Study of MC001 in Patients With Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) and Other Folate Receptor Alpha (FRα)-Expressing Solid Tumors

  NCT07909356· 1. fázis· Forrás

• Toboroz

  Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.

  NCT07755436· 1. fázis· Forrás

• Toboroz

  A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

  NCT07321106· 1. fázis· Forrás

• Toboroz

  A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  NCT07109726· 1/2. fázis· Forrás

• Toboroz

  Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

  NCT06922591· 1/2. fázis· Forrás

• Toboroz

  STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

  NCT06975293· 1/2. fázis· Forrás

• Toboroz

  A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer

  NCT06609005· 1/2. fázis· Forrás

• Toboroz

  A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

  NCT06440005· 1. fázis· Forrás

• Toboroz

  Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC

  NCT06332755· 1. fázis· Forrás

• Toboroz

  Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

  NCT06343402· 1. fázis· Forrás

• Fut, nem toboroz

  Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors

  NCT06334432· 1/2. fázis· Forrás

• Toboroz

  A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

  NCT06234423· 1. fázis· Forrás

• Fut, nem toboroz

  A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

  NCT05787587· 1. fázis· Forrás

• Fut, nem toboroz

  Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

  NCT05704985· 1. fázis· Forrás

• Toboroz

  Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

  NCT05482893· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors

  NCT05585320· 1/2. fázis· Forrás

• Toboroz

  Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

  NCT05431270· 1/2. fázis· Forrás

• Fut, nem toboroz

  A Study of NDI 1150-101 in Patients With Solid Tumors

  NCT05128487· 1/2. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Hasnyálmirigyrák5 toboroz
• Tüdőrák5 toboroz
• Petefészekrák3 toboroz
• Vastagbélrák3 toboroz
• Fej-nyaki daganatok2 toboroz
• Gyomor- és nyelőcsőrák2 toboroz
• Máj- és epeúti rák2 toboroz
• Méhtestrák2 toboroz
• Prosztatarák2 toboroz
• Szarkóma2 toboroz
• Vesedaganat2 toboroz
• Hólyagrák1 toboroz
• Méhnyakrák1 toboroz
• Melanóma1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Leállították

  Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer

  NCT07408089· 1. fázis· Forrás

• Leállították

  Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

  NCT06714617· 1. fázis· Forrás

• Leállították

  Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types

  NCT06034860· 1. fázis· Forrás

• Leállították

  Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

  NCT05827614· 1. fázis· Forrás

• Lezárult

  A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

  NCT05753722· 1. fázis· Forrás

• Leállították

  SHP2 Inhibitor BBP-398 in Combination With Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer With a KRAS Mutation

  NCT05375084· 1. fázis· Forrás

• Leállították

  A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors

  NCT05346484· 1. fázis· Forrás